Association of Certain Biochemical Parameters Related to Bone Cycle with Genotype in MPS III-B Patients
Turkish Journal of Medical Sciences · 18.02.2025 · 55 (1) · 328-336
DOI: 10.55730/1300-0144.5973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 18.02.2025. Verfasst von Seda Gökkurt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Biology and Genetics, Department of Health Sciences, Faculty of Medicine, Marmara University, İstanbul, Turkiye. Hauptthemen laut MEDLINE: Mucopolysaccharidosis III. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: The aim of this study is to investigate the genotype-phenotype correlation in Sanfilippo type B patients in terms of bone formation/resorption parameters, and to determine the release/inhibition of biomarkers accompanying osteoporosis.Materials and Methods: Plasma levels of Osteoprotegerin, Matrix metalloproteinases (MMP2, MMP9), TIMP-1, TIMP-2, BALP, Cathepsin K, and TRACP-5b were examined by ELISA method in MPS IIIB patients. At the same time, mutations in the NAGLU gene causing this disease were detected by whole exome sequencing, and their correlation with biochemical parameters was investigated.
Results
Based on the enzyme analysis results, MMP-9, TIMP1, TIMP-2, and MMP-2 were significantly high, while Cathepsin-K was low in the the study group. Osteoprotegerin levels were similar between the two groups, while Cathepsin K levels were higher in the control group. In this study, genetic analysis of patients with MPS-IIIB disease was performed. The analysis was performed by sequencing all exons and exon-intron junction regions of the NAGLU gene using a next generation sequencing system. In this way, variations were detected qualitatively with high read depths. As a result of the analyses, only 2 patients had a previously pathogenically defined alteration. In addition, as a result of the impact-assessment analyses, alterations that have a modifying effect on protein structure were also detected.
Conclusion
Regarding to genetic analysis results, it is necessary to consider the change classified as benign in the OMIM database as pathogenic because the changes (p.Arg737Gly and p.Trp103Cys) found in patients have somehow altered enzyme activity. A novel NAGLU gene mutation, p. Trp103Cys was detected in one patient. The p.Trp103Cys mutation in the first exon was shown the first time, additionally, SIFT and PolyPhen analyses confirmed this variation as "damaging." Therefore, future functional analyses of the variation can be conducted to carry out a more comprehensive study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Biology and Genetics, Department of Health Sciences, Faculty of Medicine, Marmara University, İstanbul, Turkiye.
- Division of Pediatric Genetics, Department of Pediatrics, Faculty of Medicine, Akdeniz University, Antalya, Turkiye.
ORCID-Profile: Seda Gökkurt, İrem Peker Eyüboğlu, Banu Nur Güzel, Ercan Mihçi, Ayşe Özer, Mustafa Akkiprik
Zitieren
APA
Gökkurt, S., Peker Eyüboğlu, İ., Nur Güzel, B., Mihçi, E., Özer, A., & Akkiprik, M. (2025). Association of Certain Biochemical Parameters Related to Bone Cycle with Genotype in MPS III-B Patients. Turkish Journal of Medical Sciences, 55(1), 328-336. https://doi.org/10.55730/1300-0144.5973
Vancouver
Gökkurt S, Peker Eyüboğlu İ, Nur Güzel B, Mihçi E, Özer A, Akkiprik M. Association of Certain Biochemical Parameters Related to Bone Cycle with Genotype in MPS III-B Patients. Turkish Journal of Medical Sciences. 2025;55(1):328-336. doi:10.55730/1300-0144.5973
BibTeX
@article{Gkkurt2025,
author = {Gökkurt, Seda and Peker Eyüboğlu, İrem and Nur Güzel, Banu and Mihçi, Ercan and Özer, Ayşe and Akkiprik, Mustafa},
title = {Association of Certain Biochemical Parameters Related to Bone Cycle with Genotype in MPS III-B Patients},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {1},
pages = {328--336},
doi = {10.55730/1300-0144.5973}
}
EUVIMED